CCNE1 and non-small cell lung carcinoma: A similar study reported that BM-MSC-derived exosomes can carry miR-144 which targets the expression of cyclin E1 (CCNE1) or cyclin E2 (CCNE2) and inhibit the NSCLC progression (111).